Carregant...
An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims
Objective: To evaluate the number and type of warning letters issued by the US Food and Drug Administration (FDA) to pharmaceutical manufacturers for promotional violations. Methods: Two reviewers downloaded, printed and independently evaluated warning letters issued by the FDA to pharmaceutical man...
Guardat en:
| Publicat a: | Pharmacy Practice |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Centro de investigaciones y Publicaciones Farmacéuticas
2012
|
| Matèries: | |
| Accés en línia: | https://www.redalyc.org/articulo.oa?id=69025160002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|